After Solanezumab, What’s Next? Alzheimer’s Options Take The Stage At CTAD

 
• By Mandy Jackson
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapy Areas